Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Soc Echocardiogr ; 9(4): 442-51, 1996.
Article in English | MEDLINE | ID: mdl-8827627

ABSTRACT

In anesthetized animals maintained with isoflurane using 100% oxygen as a carrier gas, Albunex (Molecular Biosystems, Inc., San Diego, Calif.) produced no ultrasound contrast in the left ventricle after intravenous administration. The current study tested the hypothesis that the inhalation of gas mixtures with increased concentrations of oxygen decreased the quality and duration of Albunex-induced contrast. Albunex (0.22 mL/kg) was injected intravenously into anesthetized dogs (n = 9) breathing compressed air, oxygen, mixtures of oxygen and nitrogen, or combinations of oxygen and nitrous oxide. Albunex produced ultrasound contrast of shorter duration and decreased quality during the inhalation of gas mixtures containing increased amounts of oxygen. In the presence of inhaled gas mixtures containing nitrous oxide, Albunex produced no contrast in the left ventricle, regardless of the oxygen content. These data indicate that the inhalation of gas mixtures containing smaller amounts of nitrogen, compared with air, decreased the ability of Albunex to cause ultrasound contrast in the heart after intravenous administration.


Subject(s)
Albumins , Contrast Media , Echocardiography , Oxygen/pharmacology , Air , Animals , Dogs , Microspheres , Nitrogen/pharmacology , Nitrous Oxide/pharmacology
2.
J Am Soc Echocardiogr ; 8(4): 465-74, 1995.
Article in English | MEDLINE | ID: mdl-7546782

ABSTRACT

A new intravenously administered ultrasound contrast agent was studied in eight dogs during intermittent coronary artery occlusion. The area of the myocardial contrast defect was compared with that of the acute wall motion abnormality induced by coronary occlusion. A close correlation was found between these two independent measures of acute myocardial ischemia. The peak change in myocardial intensity during coronary occlusion was significantly less than for the same segment before ischemia and for a remote nonischemic segment. This new, intravenously administered ultrasound contrast agent can be used to evaluate the spatial distribution of hypoperfused myocardium and should therefore prove valuable in the clinical evaluation of ischemic syndromes.


Subject(s)
Contrast Media/administration & dosage , Coronary Disease/diagnostic imaging , Echocardiography/methods , Animals , Coronary Disease/physiopathology , Dogs , Hemodynamics , Injections, Intravenous
SELECTION OF CITATIONS
SEARCH DETAIL
...